We just received data on a new analyst forecast for $DBVT. Andrew Fein from H.C. Wainwright set a price target of 16.0 for DBVT.
To track analyst ratings and price targets for $DBVT, check out Quiver Quantitative's $DBVT forecast page.
$DBVT Insider Trading Activity
$DBVT insiders have traded $DBVT stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $DBVT stock by insiders over the last 6 months:
- PHARIS MOHIDEEN (Chief Medical Officer) has made 0 purchases and 4 sales selling 3,857 shares for an estimated $2,282.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DBVT Hedge Fund Activity
We have seen 5 institutional investors add shares of $DBVT stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAKER BROS. ADVISORS LP added 1,461,425 shares (+inf%) to their portfolio in Q4 2024, for an estimated $4,515,803
- BRAIDWELL LP removed 326,108 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,007,673
- UBS GROUP AG added 162,376 shares (+inf%) to their portfolio in Q4 2024, for an estimated $501,741
- MILLENNIUM MANAGEMENT LLC removed 42,743 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $132,075
- NAN FUNG GROUP HOLDINGS LTD added 37,095 shares (+inf%) to their portfolio in Q4 2024, for an estimated $114,623
- POINT72 ASSET MANAGEMENT, L.P. removed 25,000 shares (-8.0%) from their portfolio in Q4 2024, for an estimated $77,250
- MORGAN STANLEY removed 13,762 shares (-23.1%) from their portfolio in Q4 2024, for an estimated $42,524
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
